Statistics

Total Visits

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice46

Select a period of time:

Number of views in the range

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice21

Views

Views
November 20251
December 20251
January 20260
February 20261
March 202615
April 20262
May 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Argentina3
Costa Rica1
Finland1
Kenya1
Mexico1
 

Top cities views

Views
San Jose10
Greenville1
Helsinki1
Junín1
Las Vegas1
Mendoza1
San José1
Wheelwright1
Zapopan1